Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer.
Masi G, Cupini S, Marcucci L, Cerri E, Loupakis F, Allegrini G, Brunetti IM, Pfanner E, Viti M, Goletti O, Filipponi F, Falcone A. Masi G, et al. Ann Surg Oncol. 2006 Jan;13(1):58-65. doi: 10.1245/ASO.2006.03.094. Epub 2006 Jan 1. Ann Surg Oncol. 2006. PMID: 16372158 Clinical Trial.
Maximum tolerable doses of intravenous zidovudine in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer patients. Clinical evidence of significant antitumor activity and enhancement of zidovudine-induced DNA single strand breaks in peripheral nuclear blood cells.
Falcone A, Lencioni M, Brunetti I, Pfanner E, Allegrini G, Antonuzzo A, Andreuccetti M, Malvaldi G, Danesi R, Del Tacca M, Conte PF. Falcone A, et al. Among authors: brunetti i. Ann Oncol. 1997 Jun;8(6):539-45. doi: 10.1023/a:1008249803523. Ann Oncol. 1997. PMID: 9261522 Free article. Clinical Trial.
Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study.
Falcone A, Allegrini G, Lencioni M, Pfanner E, Brunetti I, Cianci C, Galli C, Masi G, Antonuzzo A, Conte P. Falcone A, et al. Among authors: brunetti i. Cancer Chemother Pharmacol. 1999;44(2):159-63. doi: 10.1007/s002800050961. Cancer Chemother Pharmacol. 1999. PMID: 10412951 Clinical Trial.
208 results